Friday, Mar 29, 2024
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Science and Tech
Sport
Business
Rewind
...
NRI
View Point
cartoon
Columns
Education Today
Reviews
Property
Videos
Lifestyle
E-Paper
NRI
View Point
cartoon
Columns
Reviews
Education Today
Property
Videos
Lifestyle
"b-1-617-2-delta-variant"
Phase 3 trial data shows Covaxin to be 77.8% effective against Covid-19
Efficacy data also demonstrates 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant, the company said in a statement while announcing its phase 3 data analysis.
Latest News
Australia contracts Warner, Stoinis, Agar miss out on CA contracts
7 hours ago
Adhir praises economist Parakala Prabhakar for his views on electoral bonds
7 hours ago
Fire engulfs dozens of seized vehicles in Asifnagar, police launch investigation
7 hours ago
Abbas, Varsha to lead TS teams
7 hours ago
Kyrgyzstan offers second chance to medicos
7 hours ago
Telugu girl Sanvi secures place in US cricket team
7 hours ago
Wife kills husband in Karimnagar
8 hours ago
BRS candidate Kadiyam Kavya withdraws from LS contest
8 hours ago